Idera's one-for-eight reverse stock split effective June 29

By Lisa Kerner

Charlotte, N.C., June 29 - Idera Pharmaceuticals, Inc. said its previously announced one-for-eight reverse stock split became effective at the close of business June 29.

Beginning June 30, Idera's common shares will trade on a reverse split-adjusted basis, under the unchanged stock symbol IDP.

Located in Cambridge, Mass., Idera is a drug discovery and development company specializing in treatments for cancer, infectious and respiratory, and autoimmune diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.